QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 233 filers reported holding QIAGEN NV in Q2 2018. The put-call ratio across all filers is 4.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29 | -97.2% | 650 | -96.9% | 0.00% | -100.0% |
| Q4 2022 | $1,040 | -99.9% | 20,866 | -54.3% | 0.00% | -50.0% |
| Q3 2022 | $1,884,000 | +101.5% | 45,644 | +139.0% | 0.00% | +100.0% |
| Q1 2022 | $935,000 | -24.0% | 19,098 | -13.8% | 0.00% | 0.0% |
| Q4 2021 | $1,230,000 | +414.6% | 22,144 | +353.9% | 0.00% | – |
| Q3 2021 | $239,000 | +1.3% | 4,879 | 0.0% | 0.00% | – |
| Q2 2021 | $236,000 | -10.3% | 4,879 | -9.8% | 0.00% | – |
| Q1 2021 | $263,000 | +163.0% | 5,410 | +185.5% | 0.00% | – |
| Q4 2020 | $100,000 | -85.9% | 1,895 | -88.9% | 0.00% | -100.0% |
| Q1 2020 | $711,000 | +478.0% | 17,107 | +368.9% | 0.00% | – |
| Q4 2019 | $123,000 | +123.6% | 3,648 | +125.6% | 0.00% | – |
| Q4 2018 | $55,000 | +1733.3% | 1,617 | +1517.0% | 0.00% | – |
| Q3 2018 | $3,000 | -90.0% | 100 | -89.5% | 0.00% | -100.0% |
| Q1 2018 | $30,000 | -3.2% | 953 | -5.8% | 0.00% | 0.0% |
| Q4 2017 | $31,000 | -89.5% | 1,012 | -90.1% | 0.00% | -92.3% |
| Q1 2017 | $294,000 | – | 10,179 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |